Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 19, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 19, 2024Recruiting
Condition(s):Polycythemia VeraLast Updated:February 17, 2016Completed
Condition(s):Polycythemia VeraLast Updated:June 1, 2021Completed
Condition(s):Essential ThrombocythemiaLast Updated:July 29, 2015Completed
Condition(s):Polycythemia VeraLast Updated:November 28, 2016Completed
Condition(s):HealthyLast Updated:April 21, 2015Completed
Condition(s):HealthyLast Updated:September 5, 2012Completed
Condition(s):Healthy Volunteers; Pharmacokinetics/Dynamics StudyLast Updated:July 19, 2012Completed
Condition(s):Essential ThrombocythaemiaLast Updated:May 26, 2016Completed
Condition(s):Polycythemia VeraLast Updated:January 30, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.